How Congress and drug company lobbyists worked to neutralize the DEA

“The law was the crowning achievement of a multifaceted campaign by the drug industry to weaken aggressive DEA enforcement efforts against drug distribution companies that were supplying corrupt doctors and pharmacists who peddled narcotics to the black market. The industry worked behind the scenes with lobbyists and key members of Congress, pouring more than a million dollars into their election campaigns.”

Read more: https://www.washingtonpost.com/graphics/2017/investigations/dea-drug-industry-congress/

Comments are closed, but trackbacks and pingbacks are open.